LAMATTINA JOHN L sold 6.6% of their position (2.16K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $433.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/31/2026ACC: 0002001011-26-000036
Director
Since Sep 2018
-2.16K
Net shares
Net seller
$433.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.16K acquired · 4.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.16K
Price / share
$114.15
Trade value
$246.68K
% of position
7.0%
3/6/2026
30.72K→32.88K
Common Stock
Direct
Shares
−2.16K
Price / share
$200.76
Trade value
$433.84K
% of position
6.6%
3/6/2026
32.88K→30.72K
Total
Net shares
+0.00
Net value
-$187.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | M · Option Exercise | +2.16K | $114.15 | $246.68K | 7.0% | 30.72K | 32.88K |
| Common Stock Direct | 3/6/2026 | S · Sale | −2.16K | $200.76 | $433.84K | 6.6% | 32.88K | 30.72K |
| Total | +0.00 | -$187.16K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
2.16K shares
Shares
−2.16K
Strike price
114.15
Held after
0.00
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock2.16K shares | 3/6/2026 | M · Option Exercise | −2.16K | 114.15 | — | 0.00 |